Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China

Summary Background Controversy remains over whether high-risk human papillomavirus (HPV) DNA testing should be used as a primary screen for cervical cancer. The aims of our study were to assess whether HPV DNA testing could be applied to cervical-cancer screening programmes in China, as well as othe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The lancet oncology 2010-12, Vol.11 (12), p.1160-1171
Hauptverfasser: Zhao, Fang-Hui, MD, Lin, Margaret Jane, BS, Chen, Feng, BSc, Hu, Shang-Ying, MD, Zhang, Rong, MD, Belinson, Jerome L, MD, Sellors, John W, Prof, Franceschi, Silvia, MD, Qiao, You-Lin, Prof, Castle, Philip E, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!